FDA approves Watson's Goa, India, facility

CORONA, Calif. Watson Pharmaceuticals' request to use a Goa, India, facility for pharmaceutical production was approved by the Food and Drug Administration, Forbes.com reported.

Watson, a generic drug developer of over-the-counter and prescription medications, did not disclose which products would be created at the overseas facility. The company also said that it will continue to push for other product manufacturing approvals over the next several months.

Watson also stated that they anticipate a development of more than 1 billion tablets and capsules annually at the Goa plant for the U.S. market by early 2008.

In the meantime, shares of Watson closed at $30.59 on Wednesday.